References
- Waage A., Steinshamn S. Cytokine mediators of septic infections in the normal and granulocytopenic host. European Journal of Haematology 1993; 50: 243–9
- Lasky L. A. Selectins: Interpreters of cell-specific carbohydrate information during inflammation. Science 1992; 258: 964–9
- Vestweber D. Selectins: cell surface lectins which mediate the binding of leukocytes to endothelial cells. Seminars in Cell Biology 1992; 3: 211–20
- Springer T. A. Adhesion receptors of the immune system. Nature 1990; 346: 425–34
- Rosales C., Juliano R. L. Signal transduction by cell adhesion receptors in leukocytes. Journal of Leukocyte Biology 1995; 57: 189–98
- Bruserud Ø., Bergheim J., Shammas F. V., Nesthus I. Serum concentrations of tumour necrosis factor-α during chemotherapy-induced leukopenia in patients with acute leukemia and bacterial infections. Leukemia Research 1994; 18: 415–21
- Bruserud Ø., Akselsen P. E., Bergheim J., Nesthus I. Serum concentrations of E-selectin, P-selectin, 1CAM-1 and Interleukin 6 in acute leukemia patients with chemotherapy-induced leucopenia and bacterial infections. British Journal of Haematology 1995; 91: 394–402
- Bruserud Ø., Aasen I., Akselsen P. E., Bergheim J., Rasmussen G., Nesthus I. Interleukin 1 receptor antagonist (IL1RA) in acute leukaemia: IL1RA is both secreted spontaneously by myelogenous leukemia blasts and is a part of the acute phase reaction in patients with chemotherapy-induced leucopenia. European Journal of Haematology 1996, in press
- McEver R. P. GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. Journal of Cellular Biochemistry 1991; 45: 156–61
- Kansas G. S., Spertini O., Tedder T. F. Leukocyte adhesion molecule-1 (LAM-1) structure, function, genetics and evolution. Cellular and Molecular Mechanisms of Inflammation 1991; 2: 31–59
- Pigott R., Needham L. A., Edwards R. M., Walker C., Power C. Structural and functional studies of the endothelial activation antigen endothelial leucocyte adhesion molecule-1 using a panel of monoclonal antibodies. Journal of Immunology 1991; 147: 130–5
- Newman W., Beall L. D., Carson C. W., Hunder G. G., Graben N., Randhawa Z. I., Gopal T. V., Wiener-Kronish J., Matthay M. A. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. Journal of Immunology 1993; 150: 644–54
- Dunlop L. C., Skinner M. P., Bendall L. J., Favaloro E. J., Castaldi P. A., Gorman J. J., Gamble J. R., Vadas M. A., Berndt M. C. Characterization of GMP-140 as a circulating plasma protein. Journal of Experimental Medicine 1992; 175: 1147–50
- Gamble J. R., Skinner M. P., Berndt M. C., Vadas M. A. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP 140. Science 1990; 249: 414–7
- Jung T. M., Dailey M. O. Rapid modulation of homing receptors (gp90 Mel-14) induced by activators of protein kinase C. Receptor shedding due to accelrated proteolytic cleavage at the cell surface. Journal of Immunology 1990; 144: 3130–6
- Spertini O., Freedman A. S., Belvin M. P., Penta A. C., Griffin J. D., Tedder T. F. Regulation of leukocyte adhesion molecule-1 TQ1 (Leu-8) expression and shedding by normal and malignant cells. Leukemia 1991; 5: 300–8
- Schleiffenbaum B., Spertini O., Tedder T. F. Soluble L-selectin is present in human plasma at high levels and retains functional activity. Journal of Cell Biology 1992; 119: 229–38
- Ross L., Davis C. M., Molony L. A truncated recombinant intercellular adhesion molecule-1 inhibits adhesion of leukemic cell lines to upregulated endothelial cells. In vitro. Cellular and Developmental Biology 1994; 30A, 875–80
- Maio M., Pinto A., Carbone A., Zagonel V., Gloghini A., Marotta G., Cirillo D., Colombatti A., Ferrara F., Vecchio L. D., Ferrone S. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphopro-liferative disorders. Blood 1990; 76: 783–90
- Reuss-Borst M. A., Klein G., Waller H. D., MÜLler C. A. Differential expression of adhesion molecules in acute leukemia. Leukemia 1995; 9: 869–74
- Zetterberg E., Richter J. Correlation between serum level of soluble L-selectin and leukocyte count in chronic myeloid and lymphocytic leukemia and during bone marrow transplantation. European Journal of Haematology 1993; 51: 113–9
- Spertini O., Callegari P., Cordey A.-S., Hauert J., Joggi J., Von Fliedner V., Schapira M. High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium. Blood 1994; 84: 1249–56
- Stucki A., Cordey A.-S., Monai N., De Flaugergues J.-C., Schapira M., Spertini O. Cleaved L-selectin concentrations in meningeal leukaemia. Lancet 1995; 345, (i), 286–9
- Srivastava M. D., Srivastava A., Srivastava B. I. S. Soluble Interleukin 2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in haematological malignancies. Leukemia and Lymphoma 1994; 12: 241–51
- Pui C.-H., Luo X., Evans W., Martin S., Rugg A., Wilimas J., Crist W. M., Hudson M. Serum intercellular adhesion molecule-1 in childhood malignancy. Blood 1993; 82: 895–8
- Banks R. E., Gearing A. J. H., Hemingway I. K., Norfolk D. R., Perren T. J., Selby P. J. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. British Journal of Cancer 1993; 68: 122–4
- Raspadori D., Lauria F., Ventura M. A., Rondelli D., Tura S. Expression of adhesion molecules on acute leukemia blast cells and sensitivity to normal LAK activity. Annals of Haematology 1993; 67: 213–6
- Bendall L. J., Kortlepel K., Gottlieb D. J. GM-CSF enhances [L2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1. Leukemia 1995; 9: 677–84
- Pawelec G., Ehninger G., Schmidt H., MÜLler C., BÜHring H.-J., Reutter M., Busch F. W. Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from inter-feron-α treated chronic myelogenous leukaemia patients. Cancer Immunology Immunotherapy 1990; 32: 167–72
- Lenter M., Levinovitz A., Isenmann S., Vestweber D. Monospecific and common glycoprotein ligands for E-selectin and P-selectin on myeloid cells. Journal of Cell Biology 1994; 125: 471–81
- Zannettino A. C. W., Berndt M. C., Butcher C., Butcher E. C., Vadas M. A., Simmons P. J. Primitive human hematopoietic progenitors adhere to P-selectin (CD62P). Blood 1995; 85: 3466–77
- Cavenagh J. D., Gordon-Smith E. C., Gibson F. M., Gordon M. Y. Acute myeloid leukemia blast cells bind to human endothelium in vitro utilizing E-selectin and vascular adhesion molecule-1 (VCAM-1). British Journal of Haematology 1993; 85: 285–91
- Racadot E., Cahn J. Y., Brion A., Voillat L., Plouvier E., Herve P. Cytokines, cytokine receptors and adhesion molecules after allogeneic bone marrow transplantation. Bone Marrow Transplantation, suppl 1994; 1: 107
- Horn T. D., Kerker B. J., Karp J. E., Burke P. J., Hood A. F. Endothelial expression of intercellular adhesion molecule (ICAM-1) is unaffected by marrow aplasia-inducing chemotherapy. Journal of Cutaneous Pathology 1991; 18: 36–9
- Dinarello C. A. Interleukin 1 and interleukin 1 antagonism. Blood 1991; 77: 1627–52
- Kishimoto T., Akira S., Narazaki M., Taga T. Interleukin 6 family of cytokines and gp130. Blood 1995; 86: 1243–54
- Vilcek J., Lee T. H. Tumor necrosis factor. New insight into the molecular mechanisms of its multiple actions. Journal of Biological Chemistry 1991; 266: 7313–6
- Waage A., Halstensen A., Shalaby R., BrandzæG P., Kierulf P., Espevik T. Local production of Tumor necrosis factor alpha, Interleukin 1 and Interleukin 6 in meningococcal meningitis. Journal of Experimental Medicine 1989; 170: 1859–67
- Halstensen A., Ceska M., BrandtzæG P., Rendl H., Naess A., Waage A. Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease. Journal of Infectious Diseases 1993; 167: 471–5
- Ostermann H., Rothenburger M., Mesters R. M., Van De Loo J., Kienast J. Cytokine response to infection in patients with acute myelogenous leukaemia following chemotherapy. British Journal of Haematology 1994; 88: 332–7
- Steinshamn S., Brekke O.-L., Waage A. Soluble tumor necrosis factor receptors, tumor necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever. British Journal of Haematology 1995; 89: 719–24
- Rintala E., Pulkki K., Mertsola J., Nevalainen T., Nikoskelainen J. Endotoxin, Interleukin 6, and phospholipase-A2 as markers of sepsis in patients with haematological malignancies. Scandinavian Journal of Infectious Diseases 1995; 27: 39–43
- Rogy M. A., Coyle S. M., Oldenburg H. S. A, Rock C. S., Barie P. S., Van-Zee K. J., Smith C. G., Moldawer L. L., Lowry S. F. Persistently elevated soluble tumor necrosis factor receptor and Interleukin 1 receptor antagonist levels in critically ill patients. Journal of the American College of Surgery 1994; 178: 132–8
- Zucali J. R., Broxmeyer H. E., Levy D., Morse C. Lactoferrin decreases monocyte induced fibroblast production of myeloid colony-stimulating activity by suppressing monocyte release of Interleukin I. Blood 1989; 74: 1531–6
- Crouch S. P. M., Slater K. J., Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 1992; 80: 235–40